Exercise induces metallothioneins in mouse spinal cord

Neuroscience

Volumn 163, Issue 1, 2009, Pages 244-251

  Hashimoto, K ^a   Hayashi, Y ^a   Inuzuka, T ^a   Hozumi, I ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

amyotrophic lateral sclerosis; astrocyte; growth inhibitory factor; metallothionein; neurodegenerative disease; treadmill

Indexed keywords

MESSENGER RNA; METALLOTHIONEIN I; METALLOTHIONEIN II; METALLOTHIONEIN III;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; GRAY MATTER; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD; TISSUE DISTRIBUTION; TREADMILL EXERCISE; WESTERN BLOTTING;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ASTROCYTES; CELL SURVIVAL; CYTOPROTECTION; EXERCISE TEST; EXERCISE THERAPY; FREE RADICAL SCAVENGERS; MALE; METALLOTHIONEIN; MICE; MICE, INBRED C57BL; MOTOR NEURONS; NERVE TISSUE PROTEINS; OXIDATIVE STRESS; PHYSICAL CONDITIONING, ANIMAL; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SPINAL CORD; UP-REGULATION;

EID: 68349139704     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.05.067     Document Type: Article

References (42)

1. Adlard P.A., and Cotman C.W. Voluntary exercise protects against stress-induced decreases in brain-derived neurotrophic factor protein expression. Neuroscience 124 (2004) 985-992
2. Aschner M., Cherian M.G., Klaassen C.D., Palmiter R.D., Erickson J.C., and Bush A.I. Metallothionein in brain-the role in physiology and pathology. Toxicol Appl Pharmacol 142 (1997) 229-242
3. Bello-Haas V.D., Florence J.M., Kloos A.D., Scheirbecker J., Lopate G., Hayes S.M., Pioro E.P., and Mitsumoto H. A randomized controlled trial of resistance exercise in individuals with ALS. Neurology 5 (2007) 2003-2007
4. Bilsland L.G., Nirmalananthan N., Yip J., Greensmith L., and Duchen M.R. Expression of mutant SOD1 in astrocytes induces functional deficits in motoneuron mitochondria. J Neurochem 107 (2008) 1271-1283
5. Boillée S., Vande Velde C., and Cleveland D.W. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52 (2006) 39-59
6. Burns J.M., Cronk B.B., Anderson H.S., Donnelly J.E., Thomas G.P., Harsha A., Brooks W.M., and Swerdlow R.H. Cardiorespiratory fitness and brain atrophy in early Alzheimer disease. Neurology 71 (2008) 210-216
7. Cirelli C., and Tononi G. Gene expression in the brain across the sleep-waking cycle. Brain Res 885 (2000) 303-321
8. Cleveland D.W., and Rothstein J.D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2 (2001) 806-819
9. Cotman C.W., and Engesser-Cesar C. Exercise enhances and protects brain function. Exerc Sport Sci Rev 30 (2002) 75-79
10. Engesser-Cesar C., Anderson A.J., and Cotman C.W. Wheel running and fluoxetine antidepressant treatment have differential effects in the hippocampus and the spinal cord. Neuroscience 144 (2007) 1033-1044
11. Erickson J.C., Hollopeter G., Thomas S.A., Froelick G.J., and Palmiter R.D. Disruption of the metallothionein-III gene in mice: analysis of brain zinc, behavior, and neuron vulnerability to metals, aging, and seizures. J Neurosci 17 (1997) 1271-1281
12. Gómez-Pinilla F., Ying Z., Opazo P., Roy R.R., and Edgerton V.R. Differential regulation by exercise of BDNF and NT-3 in rat spinal cord and skeletal muscle. Eur J Neurosci 13 (2001) 1078-1084
13. Gong Y.H., and Elliott J.L. Metallothionein expression is altered in a transgenic murine model of familial amyotrophic lateral sclerosis. Exp Neurol 162 (2000) 27-36
14. Handschin C., and Spiegelman B.M. The role of exercise and PGC1alpha in inflammation and chronic disease. Nature 454 (2008) 463-469
15. Hennigan A., O'Callaghan R.M., and Kelly A.M. Neurotrophins and their receptors: roles in plasticity, neurodegeneration and neuroprotection. Biochem Soc Trans 35 (2007) 424-427
16. Hidalgo J., Aschner M., Zatta P., and Vašák M. Roles of the metallothionein family of proteins in the central nervous system. Brain Res Bull 55 (2001) 133-145
17. Hozumi I., Asanuma M., Yamada M., and Uchida Y. Metallothioneins and neurodegenerative diseases. J Health Sci 50 (2004) 323-331
18. Hozumi I., Inuzuka T., Hiraiwa M., Uchida Y., Anezaki T., Ishiguro H., Kobayashi H., Uda Y., Miyatake T., and Tsuji S. Changes of growth inhibitory factor after stab wounds in rat brain. Brain Res 688 (1995) 143-148
19. Hozumi I., Suzuki J.S., Kanazawa H., Hara A., Saio M., Inuzuka T., Miyairi S., Naganuma A., and Tohyama C. Metallothionein-3 is expressed in the brain and various peripheral organs of the rat. Neurosci Lett 438 (2008) 54-58
20. Hozumi I., Uchida Y., Watabe K., Sakamoto T., and Inuzuka T. Growth inhibitory factor (GIF) can protect from brain damage due to stab wounds in rat brain. Neurosci Lett 395 (2006) 220-223
21. Hozumi I., Yamada M., Uchida Y., Ozawa K., Takahashi H., and Inuzuka T. The expression of metallothioneins is diminished in the spinal cords of patients with sporadic ALS. Amyotroph Lateral Scler 9 (2008) 294-298
22. Ishigaki S., Niwa J., Ando Y., Yoshihara T., Sawada K., Doyu M., Yamamoto M., Kato K., Yotsumoto Y., and Sobue G. Differentially expressed genes in sporadic amyotrophic lateral sclerosis spinal cords-screening by molecular indexing and subsequent cDNA microarray analysis. FEBS Lett 531 (2002) 354-358
23. Irie Y., Itokazu N., Anjiki N., Ishige A., Watanabe K., and Keung W.M. Eugenol exhibits antidepressant-like activity in mice and induces expression of metallothionein-III in the hippocampus. Brain Res 1011 (2004) 243-246
24. Jiang Y.M., Yamamoto M., Kobayashi Y., Yoshihara T., Liang Y., Terao S., Takeuchi H., Ishigaki S., Katsuno M., Adachi H., Niwa J., Tanaka F., Doyu M., Yoshida M., Hashizume Y., and Sobue G. Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Ann Neurol 57 (2005) 236-251
25. Kaspar B.K., Frost L.M., Christian L., Umapathi P., and Gage F.H. Synergy of insulin-like growth factor-1 and exercise in amyotrophic lateral sclerosis. Ann Neurol 57 (2005) 649-655
26. Kirkinezos I.G., Hernandez D., Bradley W.G., and Moraes C.T. Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Ann Neurol 53 (2003) 804-807
27. Liebetanz D., Hagemann K., von Lewinski F., Kahler E., and Paulus W. Extensive exercise is not harmful in amyotrophic lateral sclerosis. Eur J Neurosci 20 (2004) 3115-3120
28. McCrate M.E., and Kaspar B.K. Physical activity and neuroprotection in amyotrophic lateral sclerosis. Neuromol Med 10 (2008) 108-117
29. Nagai M., Re D.B., Nagata T., Chalazonitis A., Jessell T.M., Wichterle H., and Przedborski S. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 10 (2007) 615-622
30. Nagano S., Satoh M., Sumi H., Fujimura H., Tohyama C., Yanagihara T., and Sakoda S. Reduction of metallothioneins promotes the disease expression of familial amyotrophic lateral sclerosis mice in a dose-dependent manner. Eur J Neurosci 13 (2001) 1363-1370
31. Penkowa M., Florit S., Giralt M., Quintana A., Molinero A., Carrasco J., and Hidalgo J. Metallothionein reduces central nervous system inflammation, neurodegeneration, and cell death following kainic acid-induced epileptic seizures. J Neurosci Res 79 (2005) 522-534
32. Puttaparthi K., Gitomer W.L., Krishnan U., Son M., Rajendran B., and Elliott J.L. Disease progression in a transgenic model of familial amyotrophic lateral sclerosis is dependent on both neuronal and non-neuronal zinc binding proteins. J Neurosci 22 (2002) 8790-8796
33. Radák Z., Kaneko T., Tahara S., Nakamoto H., Pucsok J., Sasvári M., Nyakas C., and Goto S. Regular exercise improves cognitive function and decreases oxidative damage in rat brain. Neurochem Int 38 (2001) 17-23
34. Sakamoto T., Kawazoe Y., Uchida Y., Hozumi I., Inuzuka T., and Watabe K. Growth inhibitory factor prevents degeneration of injured adult rat motoneurons. Neuroreport 14 (2003) 2147-2151
35. Siamilis S., Jakus J., Nyakas C., Costa A., Mihalik B., Falus A., and Radak Z. The effect of exercise and oxidant-antioxidant intervention on the levels of neurotrophins and free radicals in spinal cord of rats. Spinal Cord 47 (2009) 453-457
36. Skup M., Czarkowska-Bauch J., Dwornik A., Macias M., Sulejczak D., and Wiater M. Locomotion induces changes in Trk B receptors in small diameter cells of the spinal cord. Acta Neurobiol Exp (Wars) 60 (2000) 371
37. Tokuda E., Ono S., Ishige K., Naganuma A., Ito Y., and Suzuki T. Metallothionein proteins expression, copper and zinc concentrations, and lipid peroxidation level in a rodent model for amyotrophic lateral sclerosis. Toxicology 229 (2007) 33-41
38. Uchida Y., Takio K., Titani K., Ihara Y., and Tomonaga M. The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein. Neuron 7 (1991) 337-347
39. Veldink J.H., Bär P.R., Joosten E.A., Otten M., Wokke J.H., and van den Berg L.H. Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscul Disord 13 (2003) 737-743
40. Wakida K., Morimoto N., Shimazawa M., Hozumi I., Nagase H., Inuzuka T., and Hara H. Cilostazol reduces ischemic brain damage partly by inducing metallothionein-1 and -2. Brain Res 1116 (2006) 187-193
41. West A.K., Hidalgo J., Eddins D., Levin E.D., and Aschner M. Metallothionein in the central nervous system: roles in protection, regeneration and cognition. Neurotoxicology 29 (2008) 489-503
42. Ying Z., Roy R.R., Edgerton V.R., and Gómez-Pinilla F. Voluntary exercise increases neurotrophin-3 and its receptor TrkC in the spinal cord. Brain Res 987 (2003) 93-99